paclitaxel has been researched along with Adenocystic Carcinoma in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, N; Mitani, H; Nakano, K; Oki, R; Ono, M; Sato, Y; Suto, H; Takahashi, S; Tomomatsu, J; Urasaki, T; Wang, X; Yunokawa, M | 1 |
| Bastien, C; Campitiello, M; Gehin, W; Hennequin, L; Jaud, C; Longo, R; Plastino, F; Rozzi, A | 1 |
| Fujiwara, Y; Fukuda, N; Hayashi, N; Nakano, K; Ohmoto, A; Ono, M; Sato, Y; Takahashi, S; Tomomatsu, J; Urasaki, T; Wang, X; Yunokawa, M | 1 |
| Castilho, RM; Divi, V; Nör, JE; Oklejas, AE; Pearson, AT; Polverini, PJ; Rodriguez-Ramirez, C; Warner, KA; Wu, W; Zhang, Z | 1 |
| Cao, CN; Gao, L; Luo, JW; Tang, PZ; Xu, GZ; Xu, ZG | 1 |
| Camille, N; Haddad, R; Limaye, S; Misiukiewicz, KJ; Posner, M; Tishler, R | 1 |
| Fu, J; Ge, XY; Jiang, Y; Li, SL; Yang, LQ; Yang, WW | 1 |
| Dietz, A; Mekonnen, B; Mozet, C; Stumpp, P | 1 |
| Balboni, TA; Haddad, RI; Norris, CM; Posner, MR; Schoenfeld, JD; Sher, DJ; Tishler, RB | 1 |
| Caballero, M; E Sosa, A; Grau, JJ; Tagliapietra, A | 1 |
| Chen, W; Guo, W; Lin, G; Lin, L; Lin, X | 1 |
| Bauduceau, O; Bernard, O; Ceccaldi, B; Dourhte, LM; Hervé, R; Le Moulec, S | 1 |
| Arvin-Berod, C; Davy, N; Perrot, E; Poubeau, P | 1 |
| Forastiere, AA; Gilbert, J; Jennings, T; Kies, MS; Li, Y; Pinto, HA; Silverman, P | 1 |
| Blinder, R; Busse, PM; Goguen, LA; Haddad, RI; Krane, JF; Norris, CM; Posner, MR; Tishler, RB; Wirth, LJ | 1 |
| El-Naggar, AK; Gu, M; Jasser, SA; Kim, S; Myers, JN; Nong, X; Park, YW; Santillan, AA; Yazici, YD; Younes, MN | 1 |
| Martins, RG; Till, BG | 1 |
| Asbury, RF; Boros, L; Chang, AY; Garrow, GC | 1 |
1 review(s) available for paclitaxel and Adenocystic Carcinoma
| Article | Year |
|---|---|
[Therapeutic options in sinunasal adenoid cystic carcinomas--a case report and review].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenoid Cystic; Chemotherapy, Adjuvant; Combined Modality Therapy; Endoscopy; Female; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm, Residual; Orbit; Paclitaxel; Paranasal Sinus Neoplasms; Pterygopalatine Fossa; Radiotherapy, Adjuvant; Skull Neoplasms; Sphenoid Bone; Sphenoid Sinus; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
2 trial(s) available for paclitaxel and Adenocystic Carcinoma
| Article | Year |
|---|---|
Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salivary Gland Neoplasms | 2006 |
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Adenoid Cystic; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sarcoma | 1995 |
15 other study(ies) available for paclitaxel and Adenocystic Carcinoma
| Article | Year |
|---|---|
Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenoid Cystic; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies | 2023 |
Renal Metastases from a Nasal Cavity Mixed Squamous Cell and Adenoid Cystic Carcinoma: A Case Report.
Topics: Carboplatin; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Cetuximab; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Nasal Cavity; Nose Neoplasms; Paclitaxel; Palliative Care; Positron-Emission Tomography; Rare Diseases | 2020 |
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenoid Cystic; Humans; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Prospective Studies; Retrospective Studies | 2021 |
UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.
Topics: Animals; Carcinoma, Adenoid Cystic; Cell Line, Tumor; Female; Humans; Mice; Mice, SCID; Middle Aged; Oncogene Proteins, Fusion; Paclitaxel; Primary Cell Culture; Salivary Gland Neoplasms; Salivary Glands; Xenograft Model Antitumor Assays | 2018 |
Management of nasopharyngeal adenoid cystic carcinoma.
Topics: Adult; Analysis of Variance; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Combined Modality Therapy; Cranial Nerve Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Paclitaxel; Palliative Care; Retrospective Studies; Treatment Outcome | 2013 |
Organ preservation for adenoid cystic carcinoma of the larynx.
Topics: Aged; Carboplatin; Carcinoma, Adenoid Cystic; Chemoradiotherapy; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Organ Sparing Treatments; Paclitaxel | 2013 |
Reactive oxygen species and autophagy associated apoptosis and limitation of clonogenic survival induced by zoledronic acid in salivary adenoid cystic carcinoma cell line SACC-83.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Blotting, Western; Bone Density Conservation Agents; Carcinoma, Adenoid Cystic; Cell Cycle; Cell Proliferation; Cisplatin; Diphosphonates; Drug Therapy, Combination; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Imidazoles; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Reactive Oxygen Species; Salivary Gland Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zoledronic Acid | 2014 |
Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Chemoradiotherapy; Dermatitis; Disease-Free Survival; Esophagitis; Female; Humans; Male; Middle Aged; Mucositis; Paclitaxel; Prognosis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salivary Gland Neoplasms; Xerostomia | 2012 |
Metastatic adenoid cystic carcinoma of the salivary gland responding to cetuximab plus weekly paclitaxel after no response to weekly paclitaxel alone.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Adenoid Cystic; Cetuximab; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiotherapy, Adjuvant; Risk Assessment; Salivary Gland Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
[Paclitaxel-induced apoptosis in ACC-2 cells is associated with the arrest of G(2)/M].
Topics: Apoptosis; Carcinoma, Adenoid Cystic; Dose-Response Relationship, Drug; G2 Phase; Humans; Mitosis; Paclitaxel; Tumor Cells, Cultured | 2002 |
[Cylindroma of the trachea, a rate tumor with unusual evolution].
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carcinoma, Adenoid Cystic; Cisplatin; Combined Modality Therapy; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Paclitaxel; Radiography, Thoracic; Radiotherapy Dosage; Taxoids; Tracheal Neoplasms; Treatment Outcome | 2003 |
[Chemotherapy with paclitaxel for lung metastases of cystic adenoid carcinoma. A case report and review of the literature].
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Adenoid Cystic; Female; Humans; Lung Neoplasms; Paclitaxel; Pleural Neoplasms; Salivary Gland Neoplasms; Treatment Outcome | 2003 |
Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenoid Cystic; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Treatment Outcome | 2006 |
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Adenoid Cystic; Cisplatin; Disease Models, Animal; ErbB Receptors; Humans; Male; Mice; Mice, Nude; Neoplasm Metastasis; Oncogene Protein v-akt; Paclitaxel; Parotid Gland; Phosphorylation; Purines; Salivary Gland Neoplasms; Taxoids; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
Response to paclitaxel in adenoid cystic carcinoma of the salivary glands.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Adenoid Cystic; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiography; Salivary Gland Neoplasms | 2008 |